85-5829-42　Physostigmine Salicylate 25mg　462579

特徴

• Physostigmine Salicylate is a cholinesterase inhibitor with the potential to improve cognitive ability in individuals with alzheimers. In addition, as a parasympathomimetic, it is used to treat glaucoma, dry mouth, and delayed gastric emptying.
• Synonyms:2-Hydroxybenzoic Acid compd. with (3aS,8aR)-1,2,3,3a,8,8a-Hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl methylcarbamate;, 2-Hydroxybenzoic acid, compd. with (3aS-cis)-1,2,3,3a,8,8a-Hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl methylcarbamate (1:1); Physostigmine Salicylate; Physostigmine Monosalicylate; (3aS,8aR)-1,2,3,3a,8,8a-Hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-ol Methylcarbamate (Ester) Mono(2-hydroxybenzoate) (Salt); (3aS-cis)-1,2,3,3a,8,8a-Hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-ol Methylcarbamate (Ester) Mono(2-hydroxybenzoate) (Salt); Salicylic Acid, compd. with aphysostigmine (1:1); (-)-Physostigmine salicylate; Eserine Salicylate; Isopto Eserine
• Molecular Formula:C₁₅H₂₁N₃O₂•C₇H₆O₃
• Molecular Weight:413.47
• Appearance:White to pale brown solid
• Purity:≥97%
• Melting Point:>175°C (dec.)
• Solubility:DMSO (Slightly), Methanol (Slightly, Sonicated)
• Storage and Stability:May be stored at RT for short-term only. Long-term storage is recommended at -20°C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.